Description
PRINCIPIO ACTIVO: METFORMINA - LINAGLIPTINA
utilizado en el tratamiento de enfermedades inflamatorias autoinmunes
Bedoyecta Pediátrica:
Aplicación por infusión intravenosa
FLAGENASE SUSP. 250 MG. CAJA C/FCO. C/120 ML. EPROSARTAN PRINCIPIO ACTIVO: METFORMINA - LINAGLIPTINASUSTANCIA: FLAGENASE SUSP. 250 MG. CAJA C FCO. C 120 ML. FABRICANTE: LIOMONT
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
